BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 22147655)

  • 1. Factors affecting the aldosterone/renin ratio.
    Stowasser M; Ahmed AH; Pimenta E; Taylor PJ; Gordon RD
    Horm Metab Res; 2012 Mar; 44(3):170-6. PubMed ID: 22147655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Aldosterone-to-renin ratio threshold for screening primary aldosteronism in Chinese hypertensive patients].
    Chen SX; Du YL; Zhang J; Gong YC; Hu YR; Chu SL; He QB; Song YY; Zhu DL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Oct; 34(10):868-72. PubMed ID: 17217708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism.
    Mulatero P; Rabbia F; Milan A; Paglieri C; Morello F; Chiandussi L; Veglio F
    Hypertension; 2002 Dec; 40(6):897-902. PubMed ID: 12468576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of screening and confirmatory tests in the diagnosis of primary aldosteronism: need for a standardized protocol.
    Giacchetti G; Ronconi V; Lucarelli G; Boscaro M; Mantero F
    J Hypertens; 2006 Apr; 24(4):737-45. PubMed ID: 16531803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of contraceptives on aldosterone/renin ratio may vary according to the components of contraceptive, renin assay method, and possibly route of administration.
    Ahmed AH; Gordon RD; Taylor PJ; Ward G; Pimenta E; Stowasser M
    J Clin Endocrinol Metab; 2011 Jun; 96(6):1797-804. PubMed ID: 21411552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Test characteristics of the aldosterone-to-renin ratio as a screening test for primary aldosteronism.
    Jansen PM; van den Born BJ; Frenkel WJ; de Bruijne EL; Deinum J; Kerstens MN; Smulders YM; Woittiez AJ; Wijbenga JA; Zietse R; Danser AH; van den Meiracker AH
    J Hypertens; 2014 Jan; 32(1):115-26. PubMed ID: 24018605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normokalemic hyperaldosteronism in patients with resistant hypertension.
    Benchetrit S; Bernheim J; Podjarny E
    Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One-hour upright posture is an ideal position for serum aldosterone concentration and plasma renin activity measuring on primary aldosteronism screening.
    Yin G; Zhang S; Yan L; Wu M; Xu M; Li F; Cheng H
    Exp Clin Endocrinol Diabetes; 2012 Jul; 120(7):388-94. PubMed ID: 22689101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Aldosterone/plasma renin activity ratio is a sensitive parameter for screening patients with primary aldosteronism].
    Zhang HL; Liu ZJ; Shao JM; Yan JT; Wang DW
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Oct; 34(10):873-6. PubMed ID: 17217709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can Screening and Confirmatory Testing in the Management of Patients with Primary Aldosteronism be Improved?
    Stowasser M; Ahmed A; Guo Z; Wolley M; Ungerer J; McWhinney B; Poglitsch M; Gordon R
    Horm Metab Res; 2017 Dec; 49(12):915-921. PubMed ID: 29132172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of atenolol on aldosterone/renin ratio calculated by both plasma Renin activity and direct Renin concentration in healthy male volunteers.
    Ahmed AH; Gordon RD; Taylor P; Ward G; Pimenta E; Stowasser M
    J Clin Endocrinol Metab; 2010 Jul; 95(7):3201-6. PubMed ID: 20427490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are women more at risk of false-positive primary aldosteronism screening and unnecessary suppression testing than men?
    Ahmed AH; Gordon RD; Taylor PJ; Ward G; Pimenta E; Stowasser M
    J Clin Endocrinol Metab; 2011 Feb; 96(2):E340-6. PubMed ID: 20962019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of postural changes on aldosterone to plasma renin ratio in patients with suspected secondary hypertension.
    Barigou M; Ah-Kang F; Orloff E; Amar J; Chamontin B; Bouhanick B
    Ann Cardiol Angeiol (Paris); 2015 Jun; 64(3):169-74. PubMed ID: 26051856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β-Blocker withdrawal is preferable for accurate interpretation of the aldosterone-renin ratio in chronically treated hypertension.
    Browne GA; Griffin TP; O'Shea PM; Dennedy MC
    Clin Endocrinol (Oxf); 2016 Mar; 84(3):325-31. PubMed ID: 26300226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of female sex hormones and contraceptive pill on the diagnostic work-up for primary aldosteronism.
    Pizzolo F; Raffaelli R; Memmo A; Chiecchi L; Pavan C; Guarini P; Guidi GC; Franchi M; Corrocher R; Olivieri O
    J Hypertens; 2010 Jan; 28(1):135-42. PubMed ID: 19952782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cutoff value of aldosterone-to-renin ratio for the diagnosis of primary aldosteronism in patients taking antihypertensive medicine.
    Niizuma S; Nakahama H; Kamide K; Fukuchi K; Iwanaga Y; Nakata H; Yoshihara F; Horio T; Nakamura S; Kawano Y
    Clin Exp Hypertens; 2008 Oct; 30(7):640-7. PubMed ID: 18855267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laboratory diagnosis of primary aldosteronism, and drospirenone-ethinylestradiol therapy.
    Pizzolo F; Pavan C; Corrocher R; Olivieri O
    Am J Hypertens; 2007 Dec; 20(12):1334-7. PubMed ID: 18047926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indicators of mineralocorticoid excess in the evaluation of primary aldosteronism.
    Balaş M; Zosin I; Maser-Gluth C; Hermsen D; Cupisti K; Schott M; Schinner S; Knoefel WT; Scherbaum WA; Willenberg HS
    Hypertens Res; 2010 Aug; 33(8):850-6. PubMed ID: 20520614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Ramipril on the Aldosterone/Renin Ratio and the Aldosterone/Angiotensin II Ratio in Patients With Primary Aldosteronism.
    Guo Z; Poglitsch M; Cowley D; Domenig O; McWhinney BC; Ungerer JPJ; Wolley M; Stowasser M
    Hypertension; 2020 Aug; 76(2):488-496. PubMed ID: 32507039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does aldosterone-to-renin ratio predict the antihypertensive effect of the aldosterone antagonist spironolactone?
    Mahmud A; Mahgoub M; Hall M; Feely J
    Am J Hypertens; 2005 Dec; 18(12 Pt 1):1631-5. PubMed ID: 16364838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.